NCT07468058 Diabetic Retinopathy Prevalence And Risk Factors
| NCT ID | NCT07468058 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Da Nang Family General Hospital |
| Condition | Diabetic Retinopathy (DR) |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-11-25 |
| Primary Completion | 2026-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-11-25 with a primary completion date of 2026-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this retrospective observational study is to evaluate the prevalence and severity of diabetic retinopathy (DR) and to identify associated risk factors among patients with diabetes mellitus at Gia Dinh Family Hospital in Da Nang, Vietnam. The main questions it aims to answer are: 1. What is the prevalence and distribution of different stages of diabetic retinopathy among diabetic patients at this hospital? 2. Which clinical and laboratory factors are associated with the presence of diabetic retinopathy?
Eligibility Criteria
Inclusion Criteria: * Diagnosed diabetes mellitus (type 1 or type 2) according to ADA criteria * Underwent ophthalmic examination including dilated fundus examination and OCT * Available electronic medical records with key clinical and laboratory data Exclusion Criteria: * Gestational diabetes mellitus * Media opacity precluding fundus examination (advanced cataract, corneal opacity, dense vitreous hemorrhage) * Other retinal diseases (e.g., hypertensive retinopathy, retinal vein occlusion) * History of ocular trauma or intraocular surgery within 6 months
Contact & Investigator
Thao Nguyen Ngoc, Doctor of Medicine
PRINCIPAL INVESTIGATOR
Family Hospital, Da Nang, Vietnam
Frequently Asked Questions
Who can join the NCT07468058 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetic Retinopathy (DR). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07468058 currently recruiting?
Yes, NCT07468058 is actively recruiting participants. Contact the research team at ngocthao090897@gmail.com for enrollment information.
Where is the NCT07468058 trial being conducted?
This trial is being conducted at Da Nang, Vietnam.
Who is sponsoring the NCT07468058 clinical trial?
NCT07468058 is sponsored by Da Nang Family General Hospital. The principal investigator is Thao Nguyen Ngoc, Doctor of Medicine at Family Hospital, Da Nang, Vietnam. The trial plans to enroll 300 participants.